US Broker Ratings

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Understanding the 24% Potential Upside in CNS Treatments

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has garnered significant attention within the biopharmaceutical sector, particularly for its innovative approach to addressing central nervous system (CNS) disorders. With..

Qiagen N.V. (QGEN) Stock Analysis: Unveiling a 40% Upside Potential in the Diagnostics Sector

Investors looking into the healthcare sector may find Qiagen N.V. (NYSE: QGEN) an intriguing option, especially given its significant upside potential and robust position within the..

Merck & Co. (MRK) Stock Analysis: Promising Upside with Strong Buy Ratings

Investors keeping a close watch on Merck & Co., Inc. (NYSE: MRK) have reason to be optimistic. This healthcare giant, with a robust market capitalization of..

Pfizer, Inc. (PFE)

⚠️ No article content returned.

..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Potential 45.6% Upside and Strong Buy Ratings

Investors eyeing opportunities in the healthcare sector might find Prestige Consumer Healthcare Inc. (NYSE: PBH) a compelling prospect. With a market capitalization of $2.49 billion, this..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a Potential 34% Upside Amidst Current Market Dynamics

Investors seeking opportunities in the healthcare sector may find Grifols, S.A. (NASDAQ: GRFS) an intriguing prospect. With its headquarters in Barcelona, Spain, Grifols is a key..

HealthEquity, Inc. (HQY) Stock Analysis: 33% Potential Upside with Strong Buy Ratings

HealthEquity, Inc. (NASDAQ: HQY), a leading player in the health information services sector, is catching the attention of investors with a potential upside of 33.04%, according..

Alkermes plc (ALKS) Stock Analysis: Exploring a 30% Potential Upside with Robust Revenue Growth

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector specializing in drug manufacturing, presents a compelling case for investors with its significant potential upside..

Molina Healthcare Inc (MOH) Stock Analysis: Understanding the Investment Dynamics Amidst a Challenging Sector

Investors eyeing Molina Healthcare Inc (NYSE: MOH) must navigate a landscape marked by mixed signals. As a prominent player in the healthcare plans industry, Molina Healthcare..

Merit Medical Systems (MMSI) Stock Analysis: A Promising 47.93% Potential Upside

Investors looking to navigate the dynamic healthcare sector may find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing option. With a promising potential upside of 47.93%,..

STERIS plc (STE) Stock Analysis: Navigating a 34.63% Potential Upside in the Medical Devices Sector

Investors with an eye on the healthcare sector should take notice of STERIS plc (NYSE: STE), a prominent player in the medical devices industry. With a..

Abbott Laboratories (ABT) Stock Analysis: Strong Buy Ratings Signal Potential 40.7% Upside

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector, is capturing investor attention with its promising potential upside of 40.7%, as indicated by the average..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 43% Potential Upside in the Medical Device Sector

For investors keen on the healthcare sector, particularly within medical devices, Globus Medical, Inc. (NYSE: GMED) presents a compelling opportunity. With a market capitalization of $10.58..

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking the 105% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the healthcare sector, specifically within the biotechnology industry, presents an intriguing opportunity for investors seeking exposure to..

RadNet, Inc. (RDNT) Stock Analysis: Unpacking a 54% Upside Potential in the Booming Diagnostics Sector

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, is capturing the attention of investors with its substantial upside potential. With a market capitalization..

Glaukos Corporation (GKOS) Stock Analysis: A 13.15% Upside Potential in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specializes in developing innovative medical devices for ophthalmic applications. With a market capitalization of $7.84..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Strong Buy Ratings and Potential 12.33% Upside

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the healthcare sector, is making waves in the biotechnology industry with its innovative approach to treating B-cell..

Legend Biotech Corporation (LEGN): Investor Outlook with a Promising 103% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is capturing investor attention with its significant potential upside, currently estimated at 103.54%. As a noteworthy player in the biotechnology sector,..

Lantheus Holdings, Inc. (LNTH): An Investor’s Perspective on its 9.94% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) is a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization..

West Pharmaceutical Services (WST) Stock Analysis: A 7.34% Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST), a leading player in the healthcare sector, is capturing the attention of investors with its robust market position and a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds